Articles and Insights About Wearables for Clinical Trials

Articles by Rob Wilson

Rob Wilson

VP of Marketing Strategy

Find me on:

Recent Articles


VivoSense Joins CancerX to Advance Digital Innovation in Research

 Rob Wilson  June 14, 2023

On June 2, 2023, at ASCO, CancerX, a public-private partnership co-hosted by Moffitt Cancer Center and the Digital Medicine Society (DiMe), along with the Office for the National Coordinator for Health Information Technology (ONC) and the Office of the Assistant Secretary for Health (OASH), announced its founding members. VivoSense is proud to be among other organizations striving to eradicate cancer!

Read More

Digital Health Expert, Ieuan Clay, Joins VivoSense Science Team

 Rob Wilson  June 16, 2022

Vivosense is pleased to announce that Ieuan Clay has joined the company as Director of Science. He brings extensive knowledge in developing and validating novel digital measures gained across experiences in industry, healthtech and academia.

Read More

VivoSense Joins DTRA to Accelerate Adoption of Decentralized Trials

 Rob Wilson  June 9, 2022

VivoSense, an agile end-to-end digital clinical endpoint solutions company developing digital endpoints from wearable sensors with their proprietary AI-enabled software platform is proud to join an alliance of over one hundred and twenty life sciences and healthcare organizations that seek to accelerate the broad adoption of patient-focused, decentralized clinical trials and research. The Decentralized Trials & Research Alliance (DTRA), is uniting industry stakeholders, including healthcare companies, regulators, patient groups, research organizations and technology providers with a singular mission to make clinical trial participation widely accessible by advancing policies, research practices and new technologies in decentralized clinical research.

Read More
 Newer All Articles Older 

Subscribe to Email Updates

Stay Connected

Popular